Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.
1/5 보강
OpenAlex 토픽 ·
Chronic Myeloid Leukemia Treatments
Acute Lymphoblastic Leukemia research
Chronic Lymphocytic Leukemia Research
APA
Koji Sasaki, HM Kantarjian, et al. (2026). Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.. American journal of hematology. https://doi.org/10.1002/ajh.70325
MLA
Koji Sasaki, et al.. "Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.." American journal of hematology, 2026.
PMID
42031676
같은 제1저자의 인용 많은 논문 (5)
- A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110).
- Bilateral Pollicization with Amputated Index Fingers for Thumb Reconstruction in a Case with Multiple Digit Amputations.
- Circulating tumor DNA methylation and gut microbiota in colorectal cancer: diagnostic, prognostic, and therapeutic implications.
- The Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) Inhibits the Proliferation of Gastric Cancer Cells and Alters microRNA Signatures.
- Free-flap reconstruction for full-thickness oral defects involving the oral commissure combined with oral modiolus reconstruction using a fascial sling.